Skip to content
Richard Peek
Home
Contact Me
Publications
Richard Peek
←
Postprandial plasma lipidomics reveal specific alteration of hepatic-derived diacylglycerols in non-alcoholic fatty liver disease
Wild-type human PRSS2 and PRSS1R122H cooperatively initiate spontaneous hereditary pancreatitis in transgenic mice
→
Should we continue or discontinue inflammatory bowel disease medication in patients with COVID-19?
Posted on
March 11, 2022
by
Gastroenterology Journal
This entry was posted in
News
. Bookmark the
permalink
.
←
Postprandial plasma lipidomics reveal specific alteration of hepatic-derived diacylglycerols in non-alcoholic fatty liver disease
Wild-type human PRSS2 and PRSS1R122H cooperatively initiate spontaneous hereditary pancreatitis in transgenic mice
→
Links
Gastroenterology
MyVUMC
March 2022
S
M
T
W
T
F
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Feb
Apr »
Other websites
Etiological Studies of Gastric Carcinoma
H. pylori and Gastric Cancer
